When integrating these data we observed that according to their KDM4 expression pattern, a different drug set for each neoplasm can be found (Figure 6); for example, KDM4E and D are of importance for Lung Adenocarcinoma, therefore, sulpiride and balanol are FDA-approved drugs that could be considered for the treatment of that cancer. The gene discussed is KDM4E; the disease is neoplasm.